The detection of gluten immunogenic peptide (GIP) in urine and stool is a novel test, and recent studies have examined whether it has a role in monitoring and follow-up in CD, specifically regarding its use as a tool for monitoring adherence to GFD. Here, GIP is linked to Cowden disease.